Pinnacle Financial Group, Inc.’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$733K Buy
+1,402
New +$718K 0.07% 212

Other funds holding VRTX

Pinnacle Financial Group, Inc.'s VRTX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 1,402 shares worth $733K. The stake represents 0.07% of the portfolio and ranks #212 among its holdings.

1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 1,402 shares of Vertex Pharmaceuticals worth $733K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.07% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #212 holding.
  • 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.